Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)

NCT02773732 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped slow enrollment

Conditions

Leukemia
Acute Myelogenous Leukemia
Acute Myeloid Leukemia

Interventions

DRUG: Ciprofloxacin 750 MG
DRUG: Etoposide
DRUG: Ciprofloxacin 1000 MG
DRUG: Ciprofloxacin 500 mg

Sponsor

University of Florida